Bryant David Lim
Net Worth

Last updated:

What is Bryant David Lim net worth?

The estimated net worth of Mr. Bryant David Lim is at least $3,631,496 as of 25 Mar 2021. He owns shares worth $12,934 as insider, has earned $18,952 from insider trading and has received compensation worth at least $3,599,610 in Idera Pharmaceuticals, Inc..

What is the salary of Bryant David Lim?

Mr. Bryant David Lim salary is $514,230 per year as Senior Vice President, Gen. Counsel & Corporation Sec. in Idera Pharmaceuticals, Inc..

How old is Bryant David Lim?

Mr. Bryant David Lim is 54 years old, born in 1971.

What stocks does Bryant David Lim currently own?

As insider, Mr. Bryant David Lim owns shares in one company:

Company Title Shares Price per share Total value
Idera Pharmaceuticals, Inc. (IDRA) Senior Vice President, Gen. Counsel & Corporation Sec. 30,434 $0.43 $12,934

What does Idera Pharmaceuticals, Inc. do?

Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.

Bryant David Lim insider trading

Idera Pharmaceuticals, Inc.

Mr. Bryant David Lim has made 4 insider trades between 2018-2021, according to the Form 4 filled with the SEC. Most recently he sold 7,630 units of IDRA stock worth $10,377 on 25 Mar 2021.

The largest trade he's ever made was exercising 7,630 units of IDRA stock on 25 Mar 2021. As of 25 Mar 2021 he still owns at least 30,434 units of IDRA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 7,630 $1.36 $10,377
Sale
Common Stock 1,711 N/A N/A
Sale
Common Stock 1,465 $3.91 $5,722
Sale
Common Stock 1,603 $1.78 $2,853
Purchase
Common Stock 4,000 $3.05 $12,200

Idera Pharmaceuticals key executives

Idera Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: